date:Sep 18, 2018
rently healthy older adults who received daily aspirin than among those who received [a] placebo and was attributed primarily to cancer-related death. The authors added, In the context of previous studies, this result was unexpected and should be interpreted with caution.
Taken together, the three studies acknowledge that millions of people around the world are on a daily low-dose aspirin regimen, aimed at preventing heart attack and stroke.
For patients with a history of heart attack or strok